HEALTH CARE UTILIZATION AND COSTS

PUBLICATIONS

Maestri TJ,* Mican L, Rozea H, Barner JC. Do long-acting injectable antipsychotics prevent or delay hospital readmission? Psychopharmacology Bulletin. 2018;48(1):1-8.

Barner JC, Petrilla AA, Kang HA,* Shen X, Alshehri A,* Sullivan E, Troeger K, Richards KM, Blackwell SC. Fetal fibronectin testing and pregnancy outcomes among Texas Medicaid patients at risk for preterm birth. American Journal of Managed Care. 2017;23:S139-S146.

Kang HA,* Barner JC. The relationship between out-of-pocket healthcare expenditures and insurance status among individuals with Chronic Obstructive Pulmonary Disease. Journal of Pharmaceutical Health Services Research. 2017, DOI: 10.1111/jphs.12170.

Gupte K,* Kim G,* Barner JC. Impact of comorbid depression on medication adherence and asthma-related health care costs in Texas Medicaid patients with asthmaJournal of Pharmaceutical Health Services Research. 2015;6(4):197-205.

Park H,* Rascati K, Lawson KL, Barner JC, Richards K, Malone D. Health costs and outcomes associated with Medicare Part D prescription drug cost-sharing in beneficiaries on dialysis. Journal of Managed Care and Specialty Pharmacy. 2015;21(10):956-964.

Kim G,* Barner JC, Rascati KL, Richards K. Factors associated with the initiation of biologic disease modifying antirheumatic drugs in Texas Medicaid patients with rheumatoid arthritis. Journal of Managed Care and Specialty Pharmacy. 2015;21(5):401-407.

Barner JC, Lawson KA, Roberson K, Makhinova T.* Clinical and Economic Outcomes of Texas Medicaid Medication Therapy Management (MTM) Pilot. Report for Texas Health and Human Services Commission. 2015.

Desai PR,* Lawson KA, Barner JC, Rascati KL. Estimating the direct and indirect costs for community-dwelling patients with schizophrenia. Journal of Pharmaceutical Health Services Research. 2013;4:187-194.

Desai P,* Lawson KL, Barner JC, Rascati KL. Identifying patient characteristics associated with high schizophrenia-related direct medical costs in community-dwelling patients. Journal of Managed Care Pharmacy. 2013;19(6):468-477.

*Denotes student(s) at the time of the study.

PRESENTATIONS

Bamgbade B,* Barner JC, Brown CM, Ford K, Lawson W, “The impact of a culturally relevant psychoeducational intervention on depression health care seeking among African American college students” at the American Pharmacists Association Annual Meeting, Nashville, TN, March 16-19, 2018.

Bamgbade B,* Barner JC, Brown CM, Ford K, Lawson W “Utilizing the Theory of Planned Behavior to understand depression help seeking beliefs and attitudes among African American college students” at the American Pharmacists Association Annual Meeting, Nashville, TN, March 16-19, 2018.

Alshehri A,* Barner JC, Brown CM, Ford K, Rascati KL, Said A, “The relationship between Muslims’ perceptions of Islamophobia and perceived healthcare barriers” at the American Pharmacists Association Annual Meeting, Nashville, TN, March 16-19, 2018.

Van Boskerck S,* Barner JC, Pope N, Comfort M, Stallings A, Murray M. “Impact and feasibility of implementing a systematic approach for medication therapy management in the community pharmacy setting: Pilot study expansion” at the American Pharmacists Association Annual Meeting, Nashville, TN, March 16-19, 2018.

Nduaguba SO,* Chimah C,* Barner JC, Schnur K,* “Healthcare utilization and costs among post-menopausal women on adjuvant endocrine therapy” at the International Society of Pharmacoeconomics and Outcomes Research Annual Meeting, Boston, MA, May 20-24, 2017.

Park C*, Lawson KA, Barner JC, Powers DA, Rascati KL, Wilson JP. “Comorbidity measures to predict healthcare costs among elderly gynecologic cancer survivors in the US: an analysis of SEER-Medicare data” at the International Society of Pharmacoeconomics and Outcomes Research Annual Meeting, Boston, MA , May 20-24, 2017.

Park C*, Lawson KA, Barner JC, Powers DA, Rascati KL, Wilson JP. “Comorbidity measures to predict overall survival time among elderly gynecologic cancer survivors in the US: an analysis of SEER-Medicare data” at the International Society of Pharmacoeconomics and Outcomes Research Annual Meeting, Boston, MA , May 20-24, 2017.

Kanu CN,* Brown CM, Barner JC, Chapman CJ, Walker HA, “Patient activation in inflammatory bowel disease patients” at the International Society of Pharmacoeconomics and Outcomes Research Annual Meeting, Boston, MA, May 20-24, 2017.

Nduaguba SO,* Chimah C,* Barner JC, Schnur K,* “Healthcare utilization and costs among post-menopausal women on adjuvant endocrine therapy” at the International Society of Pharmacoeconomics and Outcomes Research Annual Meeting, Boston, MA, May 20-24, 2017.

Singh-Gupte K,* Wilson J, Barner JC, Hovinga C, Rascati KL, Richards KM, “Health care utilization and costs associated with potential refractory epilepsy in Texas Medicaid” at the International Society of Pharmacoeconomics and Outcomes Research Annual Meeting, Washington, DC, May 21-25, 2016.

Singh-Gupte K,* Wilson J, Barner JC, Hovinga C, Rascati KL, Richards KM, “Treatment patterns of antiepileptic drugs in patients with potential refractory epilepsy in the Texas Medicaid program” at the International Society of Pharmacoeconomics and Outcomes Research Annual Meeting, Washington, DC, May 21-25, 2016.

Singh R,* Lawson KL, Barner JC, Richards K, Sasane R, Wilson J, “Prevalence and incidence of attention deficit hyperactivity disorder among Texas Medicaid preschoolers” at the International Society of Pharmacoeconomics and Outcomes Research Annual Meeting, Washington, DC, May 21-25, 2016.

Singh R,* Lawson KL, Barner JC, Richards K, Sasane R, Wilson J, “Treatment patterns in attention deficit hyperactivity disorder among Texas Medicaid preschoolers” at the International Society of Pharmacoeconomics and Outcomes Research Annual Meeting, Washington, DC, May 21-25, 2016.

Singh R,* Lawson KL, Barner JC, Richards K, Sasane R, Wilson J, “Time-to-initiation, healthcare utilization, and costs of treatment of attention deficit hyperactivity disorder among Texas Medicaid preschoolers” at the International Society of Pharmacoeconomics and Outcomes Research Annual Meeting, Washington, DC, May 21-25, 2016.

Smith SA,* Barner JC, Jokerst J, Srinivasa M, “Pharmacists’ interventions in community and ambulatory care practice settings: estimated cost avoidance (ECA) methodology and documentation analysis” at the American Pharmacists Association Annual Meeting, Baltimore, MD, March 4-6, 2016.

Singh-Gupte K,* Wilson J, Barner JC, Hovinga C, Rascati KL, Richards KM, “Health care utilization and costs associated with potential refractory epilepsy in Texas Medicaid” at the International Society of Pharmacoeconomics and Outcomes Research Annual Meeting, Washington, DC, May 21-25, 2016.

Kang HA,* Barner JC. “Out-of-pocket healthcare expenditures among patients with chronic obstructive pulmonary disease” at the International Society of Pharmacoeconomics and Outcomes Research Annual Meeting, Philadelphia, PA, May 16-20, 2015.

Nduaguba O,* Sudhapalli P,* Barner JC. “Predictors of mammography screening among women aged 50-74” at the International Society of Pharmacoeconomics and Outcomes Research Annual Meeting, Philadelphia, PA, May 16-20, 2015.

Makhinova T,* Barner JC, Lawson KA, Roberson K. “Impact of medication therapy management (MTM) pilot program on healthcare utilization and costs among Texas Medicaid patients with hypertension” at the International Society of Pharmacoeconomics and Outcomes Research Annual Meeting, Philadelphia, PA, May 16-20, 2015.

Oladapo A,* Desai P,* Adeyemi A,* Barner JC. “Trends in attention deficit hyperactivity disorder medication use and expenditures in the United States: An analysis of 2000-2010 Medical Expenditure Panel data,” at the International Society of Pharmacoeconomics and Outcomes Research Annual Meeting, New Orleans, LA, May 18-22, 2013.

Owusu Y,* Barner JC, Lawson K, Jokerst J, Lopez . “Incident coronary heart disease in type 2 diabetes mellitus patients: Is mean glycated hemoglobin a good predictor?” at the American Association of Colleges of Pharmacy National Meeting, San Antonio, TX, July 9-13, 2011.

*Denotes student(s) at the time of the study.


Facebook link iconMake a GiftTexas Pharmacy: The University of Texas at Austin College of Pharmacy